139 related articles for article (PubMed ID: 857738)
1. The dermal inflammatory reaction in initial psoriatic lesions.
Braun-Falco O; Schmoeckel C
Arch Dermatol Res (1975); 1977 Mar; 258(1):9-16. PubMed ID: 857738
[TBL] [Abstract][Full Text] [Related]
2. The inflammatory infiltrate in psoriasis.
Christophers E; Mrowietz U
Clin Dermatol; 1995; 13(2):131-5. PubMed ID: 7780915
[No Abstract] [Full Text] [Related]
3. Characterization of mononuclear cell infiltrates in psoriatic lesions.
Bjerke JR; Krogh HK; Matre R
J Invest Dermatol; 1978 Nov; 71(5):340-3. PubMed ID: 309493
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis.
Djemadji-Oudjiel N; Goerdt S; Kodelja V; Schmuth M; Orfanos CE
Arch Dermatol Res; 1996 Nov; 288(12):757-64. PubMed ID: 8950456
[TBL] [Abstract][Full Text] [Related]
7. Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions.
Bieber T; Braun-Falco O
Acta Derm Venereol; 1989; 69(2):175-8. PubMed ID: 2564240
[TBL] [Abstract][Full Text] [Related]
8. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
9. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.
Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM
Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436
[TBL] [Abstract][Full Text] [Related]
10. Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/cytotoxic T cells in epidermis during the evolution of the lesion.
Hammar H; Gu SQ; Johannesson A; Sundkvist KG; Biberfeld P
J Invest Dermatol; 1984 Dec; 83(6):416-20. PubMed ID: 6238995
[TBL] [Abstract][Full Text] [Related]
11. 3H-thymidine labelling of epidermis and dermal infiltrate in psoriatic erythroderma.
de la Brassinne M; Lachapelle JM
Acta Derm Venereol; 1975; 55(3):171-4. PubMed ID: 50686
[TBL] [Abstract][Full Text] [Related]
12. The presence of tryptase-positive and bikunin-negative mast cells in psoriatic skin lesions.
Ashenagar MS; Sugihara K; Maeda A; Isogai R; Takahashi M; Aisu K; Horiuchi A; Aragane Y; Kawada A; Tezuka T
Arch Dermatol Res; 2007 Feb; 298(9):421-6. PubMed ID: 17146627
[TBL] [Abstract][Full Text] [Related]
13. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis.
Raychaudhuri SP; Jiang WY; Farber EM; Schall TJ; Ruff MR; Pert CB
Acta Derm Venereol; 1999 Jan; 79(1):9-11. PubMed ID: 10086850
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic disease--from skin to bone.
Ritchlin C
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):698-706. PubMed ID: 18037929
[TBL] [Abstract][Full Text] [Related]
16. [Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris].
Braun-Falco O
Hautarzt; 1976 Aug; 27(8):363-4. PubMed ID: 182658
[TBL] [Abstract][Full Text] [Related]
17. Activated and cycling lymphocytes in benign dermal lymphocytic infiltrates including psoriatic skin lesions.
Lange Wantzin G; Larsen JK; Christensen IJ; Ralfkiaer E; Tjalve M; Lund Kofoed M; Thomsen K
Arch Dermatol Res; 1985; 278(2):92-6. PubMed ID: 4096545
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells.
Morganroth GS; Chan LS; Weinstein GD; Voorhees JJ; Cooper KD
J Invest Dermatol; 1991 Mar; 96(3):333-40. PubMed ID: 2002255
[TBL] [Abstract][Full Text] [Related]
19. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
